Stay updated on Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page.

Latest updates to the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page
- Check2 days agoChange DetectedThe page now indicates recruitment is closed and adds user guidance sections; the Intervention/Treatment header formatting is updated, and the site revision is shown as v3.6.0.SummaryDifference0.4%

- Check9 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, representing a minor platform release. It does not alter the study details or content shown on the page.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a new revision of the page metadata.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page’s revision/build version has been updated from **v3.5.2** to **v3.5.3**. This reflects a platform or documentation version change rather than a change to the study information.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page.